MedPath

A study to compare the effectiveness of KETOFOL AND KETOFOL-DEXMEDETOMIDINE drugs in patients undergoing modified electroconvulsive therapy.

Phase 1
Conditions
Health Condition 1: F40-F48- Anxiety, dissociative, stress-related, somatoform and other nonpsychotic mental disordersHealth Condition 2: F01-F99- Mental, Behavioral and Neurodevelopmental disordersHealth Condition 3: F20-F29- Schizophrenia, schizotypal, delusional, and other non-mood psychotic disorders
Registration Number
CTRI/2023/09/057361
Lead Sponsor
Shri B M Patil Medical College
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

Patients with ASA Grade I & II

Exclusion Criteria

Cardiovascular disease,

Cerebrovascular disorder,

Intracranial hypertension,

Respiratory tract disease,

Glaucoma,

Presence of a pacemaker,

History of seizures,

ASA III –V physical status,

History of allergy to the study drugs,

Pregnancy

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath